Atlas Trials

A Study of TJ101 Injection Before and After CMC Change Following Subcutaneous Injection in Healthy Adult Male Subjects in China

Clinical trial NCT07300436 · COMPLETED

Trial details

NCT number
NCT07300436
Sponsor
TJ Biopharma Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Adult Males in China
Start date
2026-01-04
Primary completion
2026-03-16
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.